Lyndon J. Mitnaul, Ph.D.
Senior Director, Regeneron Genetics Center
Regeneron Pharmaceuticals, Inc.
Tarrytown, New York
Dr. Lyndon J. Mitnaul is a senior director in the Regeneron Genetics Center at Regeneron Pharmaceuticals, Inc., in Tarrytown, N.Y., where he works with cross-functional teams to support the building research collaborations and initiatives regarding human genetics.
Dr. Mitnaul received a B.S. degree in chemistry from Benedict College, in Columbia, South Carolina, a Ph.D. in biological chemistry from Pennsylvania State University, in Hershey, Pennsylvania, and performed a Postdoctoral Fellowship at St. Jude’s Children’s Research Hospital in Memphis, Tennessee. In 1997, Merck & Company recruited him into the Department of Inflammation Research where he studied HIV pathogenesis. He was later promoted to research fellow, biology program team lead, and principal scientist in the Division of Cardiovascular Diseases, where he studied lipid metabolism, arteriosclerosis and thrombotic disease.
In 2013, Dr. Mitnaul joined Research Program Management at Regeneron and helped to establish the creation of the Regeneron Genetics Center, a fully integrated human genetics center collaborating with more than 100 organizations around the world. In addition to managing genetics research, his responsibilities increased, and in 2016 he became the technologies and platform operations team lead where he managed all of Regeneron’s Large External Therapeutic Discovery collaborations. In 2021 Lyndon refocused his efforts specifically on human genetics opportunities, and he now leads new research initiatives at the Regeneron Genetics Center.
In addition to scientific research and operations, Dr. Mitnaul has a strong passion for increasing diversity in research science, and in the pharmaceutical industry. He is an active mentor to scientists and future leaders, participates on numerous Diversity, Equity and Inclusion (DE&I) Councils and Committees, and has been recognized with several awards for his efforts regarding mentoring and DE&I.